Ipsen SA (IPSEY)
Quick facts
| Ticker | IPSEY (OTC) |
|---|
Marketed products
- Sohonos · Bone · revenue 200
Sohonos works by blocking the activity of a specific receptor that helps control bone growth. - AboBoNT-A · Neurology, Aesthetics, Pain Management
AboBoNT-A is a botulinum neurotoxin type A that blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins. - BLI800 · Other
- Diosmectite (Smecta®) · Gastroenterology
Diosmectite is a natural aluminosilicate clay that absorbs water and toxins in the gastrointestinal tract to reduce diarrhea and protect the intestinal mucosa. - EGb 761® (Tanakan®) · Neurology / Cardiovascular
EGb 761 is a standardized Ginkgo biloba extract that improves blood flow and reduces oxidative stress in the brain and peripheral tissues. - Iqirvo · Metabolic
Iqirvo works by activating peroxisome proliferator-activated receptors to improve liver function. - Bylvay · Infectious Disease
Bylvay works by blocking the ileal sodium/bile acid cotransporter, a protein that helps reabsorb bile acids in the intestines. - OnaBoNT-A
- PEG 4000 (Forlax®) · Gastroenterology
PEG 4000 is an osmotic laxative that draws water into the intestinal lumen to soften stool and promote bowel movements. - Smecta · Other
- Tigan® · Gastroenterology / Antiemetic
Tigan (trimethobenzamide) blocks dopamine receptors in the chemoreceptor trigger zone to prevent nausea and vomiting.
Phase 3 pipeline
- EGb761 · Neurology / Cognitive disorders
EGb761 is a standardized Ginkgo biloba extract that enhances cerebral blood flow and provides neuroprotection through antioxidant and anti-inflammatory mechanisms. - Eziclen · Other
- Eziclen®/Izinova® · Gastroenterology
Eziclen is a bowel cleansing agent that works as an osmotic laxative to prepare the colon for endoscopic procedures. - Fortrans® · Gastroenterology
Fortrans is a polyethylene glycol (PEG)-based osmotic laxative that draws water into the bowel to promote bowel evacuation. - IPN10200 · Oncology
IPN10200 is a somatostatin receptor agonist that binds to somatostatin receptors to inhibit hormone secretion and tumor growth. - Lanreotide microparticles · Oncology, Endocrinology
Lanreotide is a somatostatin analog that binds to somatostatin receptors to inhibit the secretion of growth hormone and other hormones. - MM-398 · Oncology
MM-398 is a liposomal formulation of irinotecan that delivers the topoisomerase I inhibitor directly to tumor cells while reducing systemic toxicity. - Triptorelin Acetate PR 1-month · Oncology; Endocrinology
Triptorelin is a gonadotropin-releasing hormone (GnRH) agonist that suppresses luteinizing hormone and follicle-stimulating hormone, leading to reduced sex hormone production. - Triptorelin embonate 22.5 mg
- Triptorelin (I.N.N.) · Oncology; Endocrinology
Triptorelin is a GnRH agonist that stimulates the pituitary gland to release luteinizing hormone and follicle-stimulating hormone, initially increasing sex hormone levels before causing sustained suppression through receptor desensitization. - Triptorelin Pamoate PR 3-month · Oncology
Triptorelin Pamoate PR 3-month is a gonadotropin-releasing hormone (GnRH) agonist that works by mimicking the action of the natural hormone GnRH, leading to a decrease in sex hormone production.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: